UK markets closed

Relief Therapeutics Holding AG (RLFTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.1591+0.0019 (+1.24%)
At close: 3:59PM EDT
Full screen
Loading interactive chart…
  • EQS Group

    Relief Therapeutics Provides Update on Regulatory Interactions in the United Kingdom and European Union Relating to Lead Drug Candidate, RLF-100 (Aviptadil)

    RELIEF THERAPEUTICS Holding AG / Key word(s): Study13-Sep-2021 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics Provides Update on Regulatory Interactions in the United Kingdom and European Union Relating to Lead Drug Candidate, RLF-100 (Aviptadil)Geneva, Switzerland, September 13, 2021 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) ("Relief"), a biopharmaceutical company s

  • EQS Group

    Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Launches PKU GOLIKE(R) KRUNCH in Germany and Italy

    RELIEF THERAPEUTICS Holding AG / Key word(s): Market launch09-Sep-2021 / 22:30 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Launches PKU GOLIKE(R) KRUNCH in Germany and ItalyAPR Expands PKU GOLIKE(R) Product Line with More Convenient, Chewable Tablet OptionGeneva, Switzerland, September 9, 2021 - RELIEF THERAPEUTICS Holding AG (SIX: R

  • EQS Group

    Relief Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference

    EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Conference08.09.2021 / 07:00 Relief Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment ConferenceGeneva, Switzerland, September 8, 2021 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced that Jack Weinstein, Relief's Chief Financial Officer and Treasure